Big Move For ContraFect Corporation
ContraFect Corporation (CFRX:NASDAQ) rocketted at $1.94, representing a gain of 47%. On Thu, Apr 27, 2023, CFRX:NASDAQ touched a New 2-Week Intraday High of $2.94. The stock got featured on our News Catalysts scanner on Wed, Apr 26, 2023 at 09:20 AM in the 'BIOTECH' category. From Thu, Apr 13, 2023, the stock recorded 40.00% Up Days and 9.09% Green Days
The stock spiked on Mon, Apr 17, 2023 at $3.95 with a volume of 120M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 197.62%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 101.1%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 54.59%
- ContraFect Corporation (CFRX:NASDAQ), 46.97%
- Silence Therapeutics Plc (SLN:NASDAQ), 34.08%
- Atomera Incorporated (ATOM:NASDAQ), 32.76%
- U Power Limited (UCAR:NASDAQ), 32.19%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 24.79%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 24.74%
- Immix Biopharma Inc. (IMMX:NASDAQ), 24.32%